FIELD: biotechnologies.
SUBSTANCE: invention is related to a compound of a formula
, where R' is the below formula, and R" is hydrogen, in free form or in the form of a pharmaceutically acceptable acid-additive salt. Proposed compounds of the formula (IA) inhibit activity of DPP-IV (dipeptidylpeptidase-IV).
EFFECT: compounds are justified for application as medicinal agents designed for inhibition of DPP-IV and for treatment of conditions mediated by DPP-IV, such as achrestic diabetes.
11 cl, 2 ex, 2 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOSITION | 2006 |
|
RU2483716C2 |
| NEW SUBSTITUTED 2-CYANOPYRROLIDINES | 1999 |
|
RU2251544C2 |
| NEW COMPOSITION | 2006 |
|
RU2821230C2 |
| APPLICATION OF DPP-IV INHIBITOR FOR REDUCTION OF GLYCEMIA ACUTE EXACERBATION | 2006 |
|
RU2440143C2 |
| SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF VILDAGLIPTIN AND GLIQUIDONE | 2014 |
|
RU2585378C1 |
| DIPEPTIDYL PEPTIDASE IV INHIBITING AGENT AND PHARMACEUTICAL COMPOSITION THEREOF | 2011 |
|
RU2485952C2 |
| XANTHINE DERIVATIVE | 2016 |
|
RU2709348C2 |
| NOVEL INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND THEIR USING AS ANTICANCER AGENTS | 2002 |
|
RU2299066C2 |
| APPLICATION OF DIPEPTIDYLPEPTIDASE IV INHIBITORS | 2004 |
|
RU2385723C2 |
| AGENT OF PEPTIDE STRUCTURE, INHIBITING DIPEPTIDYL PEPTIDASE-4, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2015 |
|
RU2589258C1 |
